KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Change in Receivables (2016 - 2025)

Regeneron Pharmaceuticals has reported Change in Receivables over the past 17 years, most recently at $51.2 million for Q4 2025.

  • Quarterly results put Change in Receivables at $51.2 million for Q4 2025, down 56.54% from a year ago — trailing twelve months through Dec 2025 was -$498.1 million (down 189.91% YoY), and the annual figure for FY2025 was -$498.1 million, down 189.91%.
  • Change in Receivables for Q4 2025 was $51.2 million at Regeneron Pharmaceuticals, down from $80.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for REGN hit a ceiling of $2.8 billion in Q2 2021 and a floor of -$1.5 billion in Q3 2021.
  • Median Change in Receivables over the past 5 years was $69.3 million (2021), compared with a mean of $80.7 million.
  • Biggest five-year swings in Change in Receivables: crashed 2154.03% in 2022 and later soared 18200.0% in 2024.
  • Regeneron Pharmaceuticals' Change in Receivables stood at $584.5 million in 2021, then crashed by 137.57% to -$219.6 million in 2022, then skyrocketed by 137.66% to $82.7 million in 2023, then surged by 42.44% to $117.8 million in 2024, then plummeted by 56.54% to $51.2 million in 2025.
  • The last three reported values for Change in Receivables were $51.2 million (Q4 2025), $80.3 million (Q3 2025), and $28.2 million (Q2 2025) per Business Quant data.